Oliver Van Oekelen
- Oncology top 10%
- Hematology top 10%
- Molecular Biology
- Infectious Diseases
- Immunology
- Co-authors
- Samir ParekhSundar JagannathAlessandro LaganàMiriam MéradDeepu MadduriBhaskar UpadhyayaAdeeb RahmanAdolfo Aleman
- Topics
- Multiple Myeloma Research and Treatments (20 papers)Protein Degradation and Inhibitors (11 papers)CAR-T cell therapy research (9 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Oliver Van Oekelen
24 papers receiving 368 citations
Peers
Comparison fields: 5 of 47
- Oncology 260
- Hematology 129
- Molecular Biology 126
- Infectious Diseases 77
- Immunology 70
Countries citing papers authored by Oliver Van Oekelen
This map shows the geographic impact of Oliver Van Oekelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Van Oekelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Van Oekelen more than expected).
Fields of papers citing papers by Oliver Van Oekelen
This network shows the impact of papers produced by Oliver Van Oekelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Van Oekelen. The network helps show where Oliver Van Oekelen may publish in the future.
Co-authorship network of co-authors of Oliver Van Oekelen
This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Van Oekelen. A scholar is included among the top collaborators of Oliver Van Oekelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Van Oekelen. Oliver Van Oekelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 17 | |
| 11 | 151 | |
| 12 | 7 | |
| 13 | 7 | |
| 14 | 7 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 27 | |
| 18 | 91 | |
| 19 | 9 | |
| 20 | 6 |
About Oliver Van Oekelen
Oliver Van Oekelen is a scholar working on Hematology, Oncology and Molecular Biology, having authored 25 papers that have together received 371 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (11 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Hematology (129 citations), Oncology (260 citations) and Infectious Diseases (77 citations). Oliver Van Oekelen has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Samir Parekh, Sundar Jagannath, Alessandro Laganà, Miriam Mérad, Deepu Madduri, Bhaskar Upadhyaya, Adeeb Rahman, Adolfo Aleman, Seunghee Kim‐Schulze and Julie Teruya‐Feldstein. Their work appears in journals such as Nature Medicine, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.